Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB5 usability and safety study of pre-filled pen versus pre-filled syringe in rheumatoid arthritis
2014-004887-39Phase 2Completed
- Sponsor
- Samsung Bioepis
- Start
- Jul 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Samsung Bioepis. Primary endpoint: Injection site pain evaluation. Started Jul 2015; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-004887-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004887-39.